Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yousuke Kanayama

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Pharmaceutics|March 1, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 RadioimmunotherapyHiroki Takashima, Ryo Tsumura, Yoshikatsu Koga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2021
Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studiesKai Zhang, Hiroshi Mizuma, Yuka Nakatani, et al.
Nature Biomedical Engineering|April 5, 2022
Simultaneous visualization of multiple radionuclides in vivoAtsushi Yagishita, Shin'ichiro Takeda, Miho Katsuragawa, et al.
EJNMMI Research|April 9, 2015
(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patientsHiroaki Kurihara, Akinobu Hamada, Masayuki Yoshida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 14, 2013
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancerKenji Tamura, Hiroaki Kurihara, Kan Yonemori, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Pharmaceutics|March 1, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 RadioimmunotherapyHiroki Takashima, Ryo Tsumura, Yoshikatsu Koga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2021
Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studiesKai Zhang, Hiroshi Mizuma, Yuka Nakatani, et al.
Nature Biomedical Engineering|April 5, 2022
Simultaneous visualization of multiple radionuclides in vivoAtsushi Yagishita, Shin'ichiro Takeda, Miho Katsuragawa, et al.
EJNMMI Research|April 9, 2015
(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patientsHiroaki Kurihara, Akinobu Hamada, Masayuki Yoshida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 14, 2013
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancerKenji Tamura, Hiroaki Kurihara, Kan Yonemori, et al.
Pageof 2